Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Evangelos Briasoulis

Showing results (1-10 of 73) with videos related to

Pageof 8
Sort By:
Nature Clinical Practice. Oncology|September 28, 2007
Individualized preventive and therapeutic management of hereditary breast ovarian cancer syndromeDimitrios H Roukos, Evangelos Briasoulis
Journal of Blood Medicine|August 30, 2014
Profile of pacritinib and its potential in the treatment of hematologic disordersEleftheria Hatzimichael, Evangelos Tsolas, Evangelos Briasoulis
The Oncologist|May 2, 2007
Cancer of unknown primary site: missing primary or missing biology?George Pentheroudakis, Evangelos Briasoulis, Nicholas Pavlidis
American Journal of Blood Research|May 16, 2013
Absence of BRAF exon 15 mutations in multiple myeloma and Waldenström's macroglobulinemia questions its validity as a therapeutic target in plasma cell neoplasiasEleftheria Hatzimichael, Samuel Murray, Evangelos Briasoulis
Cancer Biology & Therapy|March 28, 2007
Molecular genetic tools shape a roadmap towards a more accurate prognostic prediction and personalized management of cancerDimitrios H Roukos, Samuel Murray, Evangelos Briasoulis
American Journal of Blood Research|January 30, 2013
Gene mutations and molecularly targeted therapies in acute myeloid leukemiaEleftheria Hatzimichael, Georgios Georgiou, Leonidas Benetatos, et al.
Clinical Prostate Cancer|March 30, 2004
Biweekly administration of low-dose docetaxel in hormone-resistant prostate cancer: pilot study of an effective subtoxic therapyVasilis Karavasilis, Evangelos Briasoulis, Olga Siarabi, et al.
PPAR Research|September 10, 2008
PPARgamma: The Portrait of a Target Ally to Cancer Chemopreventive AgentsIoannis Sainis, Katerina Vareli, Vasilios Karavasilis, et al.
Thyroid : Official Journal of the American Thyroid Association|July 21, 2005
Oxaliplatin (Eloxatin) plus irinotecan combination chemotherapy found effective in refractory metastatic insular thyroid carcinomaEvangelos Briasoulis, Demetra Rontogianni, Vasilis Karavasilis, et al.
Cancers|November 28, 2013
Alterations of MicroRNAs in Solid Cancers and Their Prognostic ValuePanagiota Chira, Katerina Vareli, Ioannis Sainis, et al.
Pageof 8

Showing results (1-10 of 73) with videos related to

Sort By:
Pageof 8
Nature Clinical Practice. Oncology|September 28, 2007
Individualized preventive and therapeutic management of hereditary breast ovarian cancer syndromeDimitrios H Roukos, Evangelos Briasoulis
Journal of Blood Medicine|August 30, 2014
Profile of pacritinib and its potential in the treatment of hematologic disordersEleftheria Hatzimichael, Evangelos Tsolas, Evangelos Briasoulis
The Oncologist|May 2, 2007
Cancer of unknown primary site: missing primary or missing biology?George Pentheroudakis, Evangelos Briasoulis, Nicholas Pavlidis
American Journal of Blood Research|May 16, 2013
Absence of BRAF exon 15 mutations in multiple myeloma and Waldenström's macroglobulinemia questions its validity as a therapeutic target in plasma cell neoplasiasEleftheria Hatzimichael, Samuel Murray, Evangelos Briasoulis
Cancer Biology & Therapy|March 28, 2007
Molecular genetic tools shape a roadmap towards a more accurate prognostic prediction and personalized management of cancerDimitrios H Roukos, Samuel Murray, Evangelos Briasoulis
American Journal of Blood Research|January 30, 2013
Gene mutations and molecularly targeted therapies in acute myeloid leukemiaEleftheria Hatzimichael, Georgios Georgiou, Leonidas Benetatos, et al.
Clinical Prostate Cancer|March 30, 2004
Biweekly administration of low-dose docetaxel in hormone-resistant prostate cancer: pilot study of an effective subtoxic therapyVasilis Karavasilis, Evangelos Briasoulis, Olga Siarabi, et al.
PPAR Research|September 10, 2008
PPARgamma: The Portrait of a Target Ally to Cancer Chemopreventive AgentsIoannis Sainis, Katerina Vareli, Vasilios Karavasilis, et al.
Thyroid : Official Journal of the American Thyroid Association|July 21, 2005
Oxaliplatin (Eloxatin) plus irinotecan combination chemotherapy found effective in refractory metastatic insular thyroid carcinomaEvangelos Briasoulis, Demetra Rontogianni, Vasilis Karavasilis, et al.
Cancers|November 28, 2013
Alterations of MicroRNAs in Solid Cancers and Their Prognostic ValuePanagiota Chira, Katerina Vareli, Ioannis Sainis, et al.
Pageof 8